Pay in installments of $3.62 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
For Your Every Summer RSVP, with Code: SUMMER15
Description
OPTICROM ALLERGY 2% ALLERGY EYE DROPS 10ML 720833What is it Opticrom Allergy Eye Drops are used in the treatment of allergic reactions such as itchy, watery, red or inflamed eyes and puffy eyelids. The solution contains 2. 0% of sodium cromoglicate. Dosage Adults and children. Apply one or two drops into each eye up to 4 times daily, or as directed by your doctor. Always read the leaflet before taking this medicine Warnings and Cautions Opticrom should not be used during pregnancy or breastfeeding

Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.6 ★★★★★
Based on 349 reviews
Sort
Product Reviews
★★★★★ 5
Quality ink
Color: Complete Set
😊
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 14, 2025
★★★★★ 5
Perfect
Color: Black
It arrived super fast and in perfect condition.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 18, 2026
★★★★★ 5
Original
Color: Black
Entrega rápida y producto original
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 14, 2026
★★★★★ 5
Worth it!!!
Color: Black
Love the colors prints out great work 👍🏾
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 19, 2025
★★★★★ 5
Tinta de sublimación
Color: Black
Increíble producto 100% recomendado
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 15, 2025




